Theranosticsin nuclear medicine and oncology

Authors

  • Sergio Baldari Department of Biomedical Sciences and of Morphological and Functional Images, Nuclear Medicine Unit, University of Messina
  • Benedetta Pagano Department of Biomedical Sciences and of Morphological and Functional Images, Nuclear Medicine Unit, University of Messina
  • Salvatore Antonio Pignata

DOI:

https://doi.org/10.6092/1828-6550/APMB.107.1.2019.SD2

Keywords:

Theranostics, Theranostic approach, PET-CT

Abstract

Nowadays, the incidence of tumors is constantly growing, affecting older patients who are frequently exhibiting comorbidities. The occurrence of side effects may represent a problem for treatment compliance of patients. In order to manage this challenge, improving patient selection, reducing adverse events and enhancing therapeutic efficacy are mandatory.The field of Nuclear Medicine provides an opportunity to perform a personalized treatment by means of the theranostic approach.The revolutionary theranostic concept consists of administrating in different dosage the same molecule (labeled with different radioisotope), for diagnostic (using the beta+ or gamma-ray emission) and therapeutic (using alpha and beta- emission) procedures.Theranostic application are employed in several fields, for instance in differentiated thyroid cancer, neuroendocrine cancer and bone metastases treatment. In the future, aneffective management of oncological patients will require new efforts for the development of novel molecular targets for theranostic use.

Downloads

Published

2019-04-18

Issue

Vol. 107 No. 1 (2019)

Section

SCHOLARLY DIALOGS

License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:
  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).